Literature DB >> 7487896

Identification of a new membrane-bound heparan sulphate proteoglycan.

J Filmus1, W Shi, Z M Wong, M J Wong.   

Abstract

The morphological changes that occur during intestinal development have been extensively described, but the molecular basis of these changes is largely unknown. As a result of our efforts to identify molecules that play a role in intestinal morphogenesis during development, we have previously isolated a cDNA that is developmentally regulated in the intestine. This cDNA, named OCI-5, was recently shown to have 20-25% identity at the protein-sequence level with glypican and cerebroglycan, two heparan sulphate proteoglycans (HSPG) that are attached to the cell membrane by a glycosyl-phosphatidylinositol (GPI) anchor. Here we provide experimental evidence indicating that OCI-5 is also a GPI-linked HSPG. We demonstrate this by showing that OCI-5 can be labelled with radioactive sulphate and can be digested by heparitinase, but not by chondroitinase. We also show that treatment with phosphatidylinositol-specific phospholipase C releases OCI-5 from the cell surface of COS cells transfected with an OCI-5 expression vector. The identification of OCI-5 as a GPI-linked HSPG confirms that this proteoglycan belongs to the same family of HSPGs that include glypican and cerebroglycan.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7487896      PMCID: PMC1136036          DOI: 10.1042/bj3110561

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  21 in total

Review 1.  Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans.

Authors:  M Bernfield; R Kokenyesi; M Kato; M T Hinkes; J Spring; R L Gallo; E J Lose
Journal:  Annu Rev Cell Biol       Date:  1992

2.  Cloning of a major heparan sulfate proteoglycan from brain and identification as the rat form of glypican.

Authors:  L Karthikeyan; P Maurel; U Rauch; R K Margolis; R U Margolis
Journal:  Biochem Biophys Res Commun       Date:  1992-10-15       Impact factor: 3.575

Review 3.  The differentiating intestinal epithelial cell: establishment and maintenance of functions through interactions between cellular structures.

Authors:  D Louvard; M Kedinger; H P Hauri
Journal:  Annu Rev Cell Biol       Date:  1992

Review 4.  Proteoglycans: many forms and many functions.

Authors:  T E Hardingham; A J Fosang
Journal:  FASEB J       Date:  1992-02-01       Impact factor: 5.191

Review 5.  Genetic analysis of proteoglycan structure, function and metabolism.

Authors:  J D Esko
Journal:  Curr Opin Cell Biol       Date:  1991-10       Impact factor: 8.382

Review 6.  Proteoglycans: structures and interactions.

Authors:  L Kjellén; U Lindahl
Journal:  Annu Rev Biochem       Date:  1991       Impact factor: 23.643

7.  Developmental regulation of neural response to FGF-1 and FGF-2 by heparan sulfate proteoglycan.

Authors:  V Nurcombe; M D Ford; J A Wildschut; P F Bartlett
Journal:  Science       Date:  1993-04-02       Impact factor: 47.728

Review 8.  The coordinated regulation of heparan sulfate, syndecans and cell behavior.

Authors:  A C Rapraeger
Journal:  Curr Opin Cell Biol       Date:  1993-10       Impact factor: 8.382

Review 9.  Integral membrane heparan sulfate proteoglycans.

Authors:  G David
Journal:  FASEB J       Date:  1993-08       Impact factor: 5.191

10.  Cerebroglycan: an integral membrane heparan sulfate proteoglycan that is unique to the developing nervous system and expressed specifically during neuronal differentiation.

Authors:  C S Stipp; E D Litwack; A D Lander
Journal:  J Cell Biol       Date:  1994-01       Impact factor: 10.539

View more
  19 in total

Review 1.  Glypicans: proteoglycans with a surprise.

Authors:  J Filmus; S B Selleck
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

2.  Signaling network involved in the GPC3-induced inhibition of breast cancer progression: role of canonical Wnt pathway.

Authors:  Dolores Fernández; Macarena Guereño; María Amparo Lago Huvelle; Magalí Cercato; María Giselle Peters
Journal:  J Cancer Res Clin Oncol       Date:  2018-09-28       Impact factor: 4.553

3.  Glypican-3 is a binding protein on the HepG2 cell surface for tissue factor pathway inhibitor.

Authors:  A E Mast; D A Higuchi; Z F Huang; I Warshawsky; A L Schwartz; G J Broze
Journal:  Biochem J       Date:  1997-10-15       Impact factor: 3.857

4.  Suppression of glypican 3 inhibits growth of hepatocellular carcinoma cells through up-regulation of TGF-β2.

Authors:  Chris K Sun; Mei-Sze Chua; Jing He; Samuel K So
Journal:  Neoplasia       Date:  2011-08       Impact factor: 5.715

5.  Persistent Polyfunctional Chimeric Antigen Receptor T Cells That Target Glypican 3 Eliminate Orthotopic Hepatocellular Carcinomas in Mice.

Authors:  Dan Li; Nan Li; Yi-Fan Zhang; Haiying Fu; Mingqian Feng; Dina Schneider; Ling Su; Xiaolin Wu; Jing Zhou; Sean Mackay; Josh Kramer; Zhijian Duan; Hongjia Yang; Aarti Kolluri; Alissa M Hummer; Madeline B Torres; Hu Zhu; Matthew D Hall; Xiaoling Luo; Jinqiu Chen; Qun Wang; Daniel Abate-Daga; Boro Dropublic; Stephen M Hewitt; Rimas J Orentas; Tim F Greten; Mitchell Ho
Journal:  Gastroenterology       Date:  2020-02-12       Impact factor: 22.682

6.  GPC-HCC model: a combination of glybican-3 with other routine parameters improves the diagnostic efficacy in hepatocellular carcinoma.

Authors:  Abdelfattah M Attallah; Mohamed El-Far; Mohamed M Omran; Mohamed A Abdelrazek; Ahmed A Attallah; Aya M Saeed; Khaled Farid
Journal:  Tumour Biol       Date:  2016-07-05

7.  Glypican-5 stimulates rhabdomyosarcoma cell proliferation by activating Hedgehog signaling.

Authors:  Fuchuan Li; Wen Shi; Mariana Capurro; Jorge Filmus
Journal:  J Cell Biol       Date:  2011-02-21       Impact factor: 10.539

8.  Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome.

Authors:  D F Cano-Gauci; H H Song; H Yang; C McKerlie; B Choo; W Shi; R Pullano; T D Piscione; S Grisaru; S Soon; L Sedlackova; A K Tanswell; T W Mak; H Yeger; G A Lockwood; N D Rosenblum; J Filmus
Journal:  J Cell Biol       Date:  1999-07-12       Impact factor: 10.539

9.  Syndecan-1 is up-regulated in ras-transformed intestinal epithelial cells.

Authors:  Z M Wong; B Choo; M Li; D J Carey; D F Cano-Gauci; R N Buick
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

10.  Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathway.

Authors:  Wei Cheng; Chia-Jen Tseng; Tom T C Lin; I Cheng; Hung-Wei Pan; Hey-Chi Hsu; Yu-May Lee
Journal:  Carcinogenesis       Date:  2008-04-15       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.